Related Experiment Video

Updated: Aug 13, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
11:27

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

Fluoxetine: a review of receptor and functional effects and their clinical implications

C M Beasley1, D N Masica, J H Potvin

  • 1Division of Clinical Neurosciences, Eli Lilly and Company, Indianapolis, IN 46285.

Psychopharmacology
|January 1, 1992
PubMed

Insights

Subchronic fluoxetine exposure in rodents primarily downregulates serotonin 5-HT1 receptors. This selective action on serotonin receptors distinguishes fluoxetine from other antidepressants.

Area of Science:

  • Neuropharmacology
  • Central Nervous System (CNS) Research
  • Drug Action Mechanisms

Background:

  • Subchronic exposure to fluoxetine is a common research model.
  • Fluoxetine's effects on various neurotransmitter receptors are not fully elucidated.
  • Understanding receptor-specific neural effects is crucial for antidepressant development.

Purpose of the Study:

  • To review the neural effects of subchronic fluoxetine exposure on CNS receptors in rodents.
  • To clarify the impact of fluoxetine on serotonin (5-HT1, 5-HT2), cholinergic muscarinic, and beta-adrenergic receptors.
  • To evaluate electrophysiologic evidence for fluoxetine's mechanism of action.

Main Methods:

  • Literature review of studies on subchronic fluoxetine exposure in rodents.
  • Analysis of receptor binding assays and functional studies (e.g., cAMP generation).
  • Examination of electrophysiologic data investigating serotonergic transmission.

Main Results:

  • Consistent downregulation of serotonin 5-HT1 receptors is frequently reported, though not universal.
  • Effects on serotonin 5-HT2 receptors are mixed.
  • No significant effects observed on cholinergic muscarinic receptors.
  • Controversial findings regarding beta-adrenergic receptors, with limited evidence for downregulation.
  • Electrophysiology supports fluoxetine's facilitation of serotonergic transmission via autoreceptor downregulation.

Conclusions:

  • Subchronic fluoxetine exhibits specificity and selectivity in its neural effects, particularly on serotonin receptors.
  • Downregulation of presynaptic inhibitory autoreceptors contributes to enhanced net serotonergic transmission.
  • These distinct actions position fluoxetine as a unique therapeutic option among antidepressants.

More Related Videos

Exploring the Neural Correlates of Cognitive Reappraisal in Obsessive-Compulsive Disorder Using Task-based Functional Magnetic Resonance Imaging09:14

Exploring the Neural Correlates of Cognitive Reappraisal in Obsessive-Compulsive Disorder Using Task-based Functional Magnetic Resonance Imaging

Published on: March 14, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Related Concept Videos

G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...